Jiangsu Hengrui Pharmaceuticals Co.,Ltd (600276.SS)

Shanghai · Healthcare · Drug Manufacturers - Specialty & Generic
47.00 CNY+0.26%As of 2026-11-22 · CNY
Last session low 45.76 CNYLast session high 47.18 CNY
52-week low 41.89 CNY52-week high 65.83 CNY
Market cap (USD)
$46.72B
Sector
Healthcare
P/E (TTM)
35.1x
Dividend yield
0.43%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in CNY.

IndicatorValueReading
RSI (14)44.9In the neutral range (30 to 70)
MACD (12, 26, 9)0.05Below its signal line (0.34); histogram -0.30
Bollinger %B (20, 2)24%Inside the bands (45.91 to 50.50)
SMA 2048.21Price is 2.5% below
SMA 5046.54Price is 1.0% above
SMA 20051.68Price is 9.1% below
ATR (20)2.77% of priceAverage true range per day
52-week position21%In the lower part of the 41.89 to 65.83 range

About Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

Latest fiscal yearEnded 2025-12-31: revenue of 31.63B CNY and an operating margin of 27.2%.

More in Drug Manufacturers - Specialty & Generic